Human ubiquitous JCV(CY) T-antigen gene induces brain tumors in experimental animals

Oncogene

Volumn 18, Issue 1, 1999, Pages 39-46

  Krynska, Barbara ^a   Otte, Jessica ^a   Franks, Roberta ^b   Khalili, Kamel ^a   Croul, Sidney ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Brain tumors; Human virus; Transgenic mice

Indexed keywords

MESSENGER RNA; VIRUS T ANTIGEN;

ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BODY POSTURE; BRAIN STEM; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM; CEREBELLUM; DEMYELINATING DISEASE; GENE CONTROL; GENE EXPRESSION REGULATION; GROOMING; IMMUNE DEFICIENCY; JC VIRUS; MEDULLOBLASTOMA; MOUSE; NEUROECTODERM TUMOR; NEUROPATHOLOGY; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROMOTER REGION; PROTEIN EXPRESSION; TISSUE SPECIFICITY; TRANSGENIC MOUSE; URINALYSIS;

ANIMALIA; JC VIRUS; MUS MUSCULUS; PAPOVAVIRIDAE;

EID: 0033531233     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202278     Document Type: Article

References (43)

1. Arthur RR and Shah KV. (1989). Prog. Med. Virol., 36, 42-61.
2. Arthur RR, Dagostin S and Shah KV. (1989). J. Clin. Microbiol., 21, 1174-1179.
3. Astrom K-E, Mancall EL and Richardson EP, Jr. (1958). Brain, 81, 93-127.
4. Berger JR and Concha M. (1995). J. NeuroVirology, 1, 5-18.
5. Castaigne P, Rondot P, Escourolle R, Ribadeau-Dumas J-L, Cathala F and Hauw J-J. (1974). Rev. Neurol., 130, 379-392.
6. Coleman DV, Wolfendale MR, Daniel RA, Dhanjal NK, Gardner SD, Gibson PE and Field AM. (1980). J. Inf. Dis., 142, 1-8.
7. Dorries K, Vogel E, Gunther S and Czub S. (1994). Virology, 198, 59-70.
8. Egan JD, Ring BL, Reding MJ, Wells IC and Shuman RM. (1980). Transplantation 29, 84-86.
9. Feigenbaum L, Hinrichs SH and Jay G. (1992). J. Virology 66, 1176-1182.
10. Franks RR, Rencic A, Gordon J, Zoltick PW, Curtis M, Knobler RL and Khalili K. (1996). Oncogene, 12, 2573-2578.
11. Frisque RJ, Rifkin DB and Walker DL. (1980). J. Virol., 35, 265-269.
12. Frisque RJ, Bream GL and Cannella MT. (1984). J. Virol., 51, 458-469.
13. Frisque RJ and White FA. (1992). The molecular biology of JC virus causative agent of progressive multifocal leukencephalopathy. In: Roos R. (ed.) Molecular Neurovirology. Humana Press: Totowa, New Jersey, pp 25-158.
14. Fung KM and Trojanowski JQ. (1995). J. Neuropathol. Exp. Neurol., 54, 285-296.
15. Gardner SD, MacKenzie EFD, Smith C and Porter AA. (1984). J. Clin. Path., 37, 578-586.
16. Gordon JW and Ruddle FH. (1983). Methods Enzymol, 101, 411-433.
17. Ho K-C, Garancis JC, Paegle RD, Gerber MA and Borkowski WJ. (1980). Acta Neuropathol., 52, 81-83.
18. Ishaq M and Stoner GL. (1994). Proc. Natl. Acad. Sci. USA, 91, 8283-8287.
19. Krynska B, Gordon J, Otte J, Franks R, Knobler R, Giordano A, De Luca A and Khalili K. (1997). J. Cell. Biochem., 67, 223-230.
20. Liberski PP, Alwasiak J and Wegrzyn Z. (1982). Neuropat. Pol., 20, 3-4.
21. Loeber G and Dorries K. (1988). J. Virol., 62, 1730-1735.
22. Matsushima T, Nakamura K, Oka T, Tachikawa N, Sata T, Murayama S, Nukina N and Kanazawa I. (1997). Neurology, 48, 279-282.
23. Myers C, Frisque RJ and Arthur RR. (1989), J. Virol., 63, 4445-4449.
24. Ohashi T, ZuRhein GM, Varakis JN, Padgett BL and Walker DL. (1978). J. Neuropathol. Exp. Neurol., 37, 667.
25. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ and Dessel BH. (1971). Lancet i, 1257-1260.
26. Raj G and Khalili K. (1995). Virology. 213, 283-291.
27. Raj GV, Gordon J, Logan TJ, Hall DJ, De Luca A, Giordano A and Khalili K. (1995). Int. J. Oncol., 7, 801-808.
28. Rencic A, Gordon J, Otte J, Curtis M, Kovatich A, Zoltick P, Khalili K and Andrews D. (1996). Proc. Natl. Acad. Sci. USA, 93, 7352-7357.
29. Sima AF, Finkelstein SD and McLachlan DR. (1983). Ann. Neurol., 14, 183-188.
30. Small JA, Scangos G, Cork L, Jay G and Khoury G. (1986a). Cell, 46, 13-18.
31. Small JA, Khoury G, Jay G, Howley PM and Scangos GA. (1986b). Proc. Natl. Acad. Sci. USA, 83, 8288-8292.
32. Suri C, Fung BP, Tischler AS and Chikaraishi DM. (1993). J. Neurosci., 13, 1280-1291.
33. Tornatore C, Berger JR, Houff SA, Curfmann B, Meyers K, Winfield D and Major EO. (1992). Ann. Neurol., 31, 454-462.
34. Vago L, Cinque P, Sala E, Nebuloni M, Caldarelli R, Racca S, Ferrante P, Trabattoni GR and Costanzi G. (1996). 12, 139-146.
35. Varakis J, ZuRhein GM, Padgett BL and Walker DL. (1976). Cancer Res., 38, 1718-1722.
36. Walker DL, Padgett BL, ZuRhein GM, Albert A and Marsh RF. (1973). Science. 181, 674-676.
37. Weiner LP, Herndon RM, Narayan O, Johnson RT, Shah K, Rubenstein LJ, Preziosi TJ and Conley FK. (1972). N. Engl. J. Med., 286, 385-390.
38. White FA, III, Ishaq M, Stoner GL and Frisque RJ. (1992). J. Virol., 66, 5726-5734.
39. Yogo Y, Kitamura T, Sugimoto C, Ueki T, Aso Y, Hara K and Taguchi F. (1990). J. Virol., 65, 2422-2428.
40. ZuRhein GM and Chou SM. (1965). Science. 148, 1477-1479.
41. ZuRhein GM and Varakis J. (1975). Morphology of brain tumors induced by Syrian hamsters after inoculation with JC virus, a new human papovavirus. In: Kornyey S, Tariska S and Gosztonyi G. (eds.). Proceedings, VIIth International Congress of Neuropathology, vol. 1., Akademia Kiado: Budapest. pp 479-481.
42. ZuRhein GM. (1983). Studies of JC virus-induced nervous system tumors in the Syrian hamster. A review in: Sever JL and Madden DM. (eds.). Polyomaviruses and Human Neurological Disease. Alan R Liss: New York, pp 205-221.
43. ZuRhein GM. (1987). Human virus in experimental neurooncogenesis. In: Grundmann E. (ed.). Cancer Campaign: Experimental NeuroOncology, Brain Tumor, and Pain Therapy, vol 10., Gustav, Fischer: Stuttgart. pp 19-46.